Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma-Reference-Cited by-同舟云学术

Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma

Published:2008-10-15 Issue:8 Volume:113 Page:2139-2145
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Atkins Michael B.,Sosman Jeffrey A.,Agarwala Sanjiv,Logan Theodore,Clark Joseph I.,Ernstoff Marc S.,Lawson David,Dutcher Janice P.,Weiss Geoffrey,Curti Brendan,Margolin Kim A.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.23805/fullpdf

Reference33 articles.

1. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival;Amer;Cancer,1978

2. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma;Sampson;J Neurosurg,1998

3. Cytokine-based therapy and biochemotherapy for advanced melanoma;Atkins;Clin Cancer Res,2006

4. Relapse in the central nervous system in melanoma patients successfully treated with biomodulators;Mitchell;J Clin Oncol,1989

5. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients;Wronski;J Neurosurg,2000

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

2. Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?;Journal of Neuro-Oncology;2022-06-04

3. Melanoma Brain Metastases in the Era of Target Therapies: An Overview;Cancers;2020-06-21

4. Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions;Pigment Cell & Melanoma Research;2020-01-19

5. Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments;Frontiers in Cell and Developmental Biology;2019-12-04